Cargando…

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

Tumor cells are characterized as redox-heterogeneous intracellular microenvironment due to the simultaneous overproduction of reactive oxygen species and glutathione. Rational design of redox-responsive drug delivery systems is a promising prospect for efficient cancer therapy. Herein, six paclitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bingjun, Luo, Cong, Zhang, Xuanbo, Guo, Mengran, Sun, Mengchi, Yu, Han, Chen, Qin, Yang, Wenqian, Wang, Menglin, Zuo, Shiyi, Chen, Pengyu, Kan, Qiming, Zhang, Haotian, Wang, Yongjun, He, Zhonggui, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642185/
https://www.ncbi.nlm.nih.gov/pubmed/31324811
http://dx.doi.org/10.1038/s41467-019-11193-x
_version_ 1783436931869179904
author Sun, Bingjun
Luo, Cong
Zhang, Xuanbo
Guo, Mengran
Sun, Mengchi
Yu, Han
Chen, Qin
Yang, Wenqian
Wang, Menglin
Zuo, Shiyi
Chen, Pengyu
Kan, Qiming
Zhang, Haotian
Wang, Yongjun
He, Zhonggui
Sun, Jin
author_facet Sun, Bingjun
Luo, Cong
Zhang, Xuanbo
Guo, Mengran
Sun, Mengchi
Yu, Han
Chen, Qin
Yang, Wenqian
Wang, Menglin
Zuo, Shiyi
Chen, Pengyu
Kan, Qiming
Zhang, Haotian
Wang, Yongjun
He, Zhonggui
Sun, Jin
author_sort Sun, Bingjun
collection PubMed
description Tumor cells are characterized as redox-heterogeneous intracellular microenvironment due to the simultaneous overproduction of reactive oxygen species and glutathione. Rational design of redox-responsive drug delivery systems is a promising prospect for efficient cancer therapy. Herein, six paclitaxel-citronellol conjugates are synthesized using either thioether bond, disulfide bond, selenoether bond, diselenide bond, carbon bond or carbon-carbon bond as linkages. These prodrugs can self-assemble into uniform nanoparticles with ultrahigh drug-loading capacity. Interestingly, sulfur/selenium/carbon bonds significantly affect the efficiency of prodrug nanoassemblies. The bond angles/dihedral angles impact the self-assembly, stability and pharmacokinetics. The redox-responsivity of sulfur/selenium/carbon bonds has remarkable influence on drug release and cytotoxicity. Moreover, selenoether/diselenide bond possess unique ability to produce reactive oxygen species, which further improve the cytotoxicity of these prodrugs. Our findings give deep insight into the impact of chemical linkages on prodrug nanoassemblies and provide strategies to the rational design of redox-responsive drug delivery systems for cancer therapy.
format Online
Article
Text
id pubmed-6642185
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66421852019-07-22 Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy Sun, Bingjun Luo, Cong Zhang, Xuanbo Guo, Mengran Sun, Mengchi Yu, Han Chen, Qin Yang, Wenqian Wang, Menglin Zuo, Shiyi Chen, Pengyu Kan, Qiming Zhang, Haotian Wang, Yongjun He, Zhonggui Sun, Jin Nat Commun Article Tumor cells are characterized as redox-heterogeneous intracellular microenvironment due to the simultaneous overproduction of reactive oxygen species and glutathione. Rational design of redox-responsive drug delivery systems is a promising prospect for efficient cancer therapy. Herein, six paclitaxel-citronellol conjugates are synthesized using either thioether bond, disulfide bond, selenoether bond, diselenide bond, carbon bond or carbon-carbon bond as linkages. These prodrugs can self-assemble into uniform nanoparticles with ultrahigh drug-loading capacity. Interestingly, sulfur/selenium/carbon bonds significantly affect the efficiency of prodrug nanoassemblies. The bond angles/dihedral angles impact the self-assembly, stability and pharmacokinetics. The redox-responsivity of sulfur/selenium/carbon bonds has remarkable influence on drug release and cytotoxicity. Moreover, selenoether/diselenide bond possess unique ability to produce reactive oxygen species, which further improve the cytotoxicity of these prodrugs. Our findings give deep insight into the impact of chemical linkages on prodrug nanoassemblies and provide strategies to the rational design of redox-responsive drug delivery systems for cancer therapy. Nature Publishing Group UK 2019-07-19 /pmc/articles/PMC6642185/ /pubmed/31324811 http://dx.doi.org/10.1038/s41467-019-11193-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sun, Bingjun
Luo, Cong
Zhang, Xuanbo
Guo, Mengran
Sun, Mengchi
Yu, Han
Chen, Qin
Yang, Wenqian
Wang, Menglin
Zuo, Shiyi
Chen, Pengyu
Kan, Qiming
Zhang, Haotian
Wang, Yongjun
He, Zhonggui
Sun, Jin
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title_full Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title_fullStr Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title_full_unstemmed Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title_short Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
title_sort probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642185/
https://www.ncbi.nlm.nih.gov/pubmed/31324811
http://dx.doi.org/10.1038/s41467-019-11193-x
work_keys_str_mv AT sunbingjun probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT luocong probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT zhangxuanbo probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT guomengran probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT sunmengchi probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT yuhan probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT chenqin probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT yangwenqian probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT wangmenglin probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT zuoshiyi probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT chenpengyu probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT kanqiming probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT zhanghaotian probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT wangyongjun probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT hezhonggui probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy
AT sunjin probingtheimpactofsulfurseleniumcarbonlinkagesonprodrugnanoassembliesforcancertherapy